We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Destiny Pharma Plc | LSE:DEST | London | Ordinary Share | GB00BDHSP575 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.50 | -2.99% | 16.25 | 16.00 | 16.50 | 16.75 | 15.00 | 16.75 | 1,536,814 | 16:04:28 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -6.5M | -0.0683 | -2.38 | 15.48M |
Date | Subject | Author | Discuss |
---|---|---|---|
02/2/2024 17:19 | Did say if support didn't hold likely to see 30-35p here now . Unfortunately the market is brutal and have to take your profits when you can and hope to buy back in at the bottom | bones698 | |
02/2/2024 17:15 | Because the own around 1.3% | john henry | |
02/2/2024 17:01 | Why don’t you think they would issue a tr1 John? | brooko19 | |
02/2/2024 16:59 | He's a presenter on Vox markets. | captain james t kirk | |
02/2/2024 16:53 | talk on lse site that some trader called justin waite has sold out yesterday and possibly his followers | arab3 | |
02/2/2024 15:58 | thanks banshee | arab3 | |
02/2/2024 15:48 | The volume of selling has been really heavy considering the low free float | john henry | |
02/2/2024 15:46 | If its wade furniture dumping then there will be no TR1 | john henry | |
02/2/2024 15:43 | Wade (the family) have been in since pre float with roughly 6million, though they seem to have done some switching between owner/spouse and Wade the company during the post float period. | banshee | |
02/2/2024 15:41 | Unfortunately I don't think the bottom is in yet. If a company has good fundamentals the 3 day rule would normally indicate a bottom and consolidation. All I can say is Weds news must have been really bad. | john henry | |
02/2/2024 15:20 | So in the space of one RNS, Tovey has gone from hero to zero. He could have put a stop to all the speculation by undertaking a Proactive interview to answer all the questions being raised on these forums. Instead, he’s chosen radio silence and seems happy to see the share price plunge from 70p to 45p. Well done sir, carry on the good work! | henley2 | |
02/2/2024 15:17 | when or what price did wade furniture buy in JH ? | arab3 | |
02/2/2024 15:16 | Over 4m volume in 3 days there has to be a tr1 getting typed up | brooko19 | |
02/2/2024 15:14 | The market will correct itself once the fear of how quick it’s dropped goes imagine selling down here then XF73 news lands… I’m happy to hold and top up once the bottom is confirmed I still do not believe anything in that RNS warranted anywhere near this drop, some people may and have sold and I respect their view but don’t agree which is why I still hold. My opinion is that most selling are doing so because they are panicked or because JW was stopped out. | brooko19 | |
02/2/2024 15:03 | Appears the market has completely forgot about XF73 Nasal | john henry | |
02/2/2024 15:00 | One broker now no longer joint, share price sizeable drop, an underwhelming RNS: just wondering if a cash raise may now ensue ( whether to strengthen the company's hand or other) given that all options are being considered. Today's fall is worrying as its sharp and on top of a week of southerly decline. How about re-assuring the share base Mr Tovey? | carlisle44 | |
02/2/2024 14:54 | I don't know if it's true but I've just seen on the other thread that Justin Wade an uberbull of Destiny, was stopped out at 60p but it is alleged that he has said he is glad because of the delay. I find that strange given the lead product is unaffected, but would help explain such a sharp fall. | captain james t kirk | |
02/2/2024 14:50 | IMHO a large holder probably the same holder who's been dumping stock for months is offloading at any price and triggering stops.Wade Furniture?? | john henry | |
02/2/2024 14:45 | My reading of the rns is that Sebela were in agreement that the manufacturers of M3 should be changed and the drug produced in tablet form. It's however in their remit as to whether they want to de risk the phase 3 trial with a further phase 2 trial. Product will not be available until H2 24 so any change to their development plan will put the project quite a way back and I'd imagine that is why the market is so negative. In a nutshell there is uncertainty. I don't believe there is a problem with Sebela proceeding, but it could be delayed by more than the circa 6 months due to product changes. That said perhaps CT wants it back but that's me being mischievous. | captain james t kirk | |
02/2/2024 14:37 | My guess is having consulted with Sebela Dest would not have changed the formulation from Liquid to solid if that put at risk the JV. | john henry | |
02/2/2024 14:29 | JH The reformulation is under the remit i.e authority and control - of Dest, following their own review. The only reference to Sebal being involved is that that have had/agreed to change their manufacturing and control contract alongside Dest. It may be that they are happy to simply rerun phase 2, but also possible this will trigger an internal re-review of the project if that is the option recommended. | banshee | |
02/2/2024 14:10 | Just spotted your post Brooko but who knows what Tovey is thinking | marvelman | |
02/2/2024 14:09 | the rumour did not happen the rns was disappointing hopeful punters all sold | arab3 | |
02/2/2024 14:09 | I do hope this is not a prelude to a pre-emptive cash raise even though we know they have enough funds to end of year | marvelman |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions